Long-Term Survival of Patients with Metastatic Non-Small-Cell Lung Cancer over Five Decades
Objective. Novel therapeutics and supportive care improved outcomes for metastatic non-small-cell lung cancer (mNSCLC) patients. Major advances over the past five decades include the introduction of combination chemotherapy, small molecules targeting mutant proteins, especially EGFR, and more recent...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2021/7836264 |